Weekly Report: what happened at XHE last week (0415-0419)?

Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?

Weekly Market Pulse: Are Higher Interest Rates Good For The Economy?

Interest rates surged last week on the back of a hotter-than-expected inflation report. The rise in rates last week pushed the 10-year to its highest level since the peak at 5% in October of last year. Gold has been setting new highs, trading above $2400.

Weekly Report: what happened at XHE last week (0408-0412)?

Weekly Report: what happened at XHE last week (0401-0405)?

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

Weekly Report: what happened at XHE last week (0325-0329)?

Cons Disc distribution & retail has the highest dispersion among S&P groups - MS

Consumer discretionary distribution & retail has the highest dispersion among S&P groups. Morgan Stanley analysts monitored the dispersion metrics of the S&p 500 and its sectors and subsectors. Dispersion measures the range of returns for a group, Morgan Stanley says. High dispersion present in auto and household, lower in utilities and energy.

Weekly Report: what happened at XHE last week (0318-0322)?

Taking Stock: Q2 2024 Equity Market Outlook

IHI: Technological Advances Will Continue Carrying This High-Performing Medical ETF

IShares U.S. Medical Devices ETF has demonstrated the greatest long-term performance among peer funds. Abbott Laboratories and Intuitive Surgical are key holdings of the fund. The fund is uniquely postured for growth looking forward due to its mix of top holdings. IHI has outperformed the S&P 500 Index over the past decade. The iShares fund has the highest expense ratio compared to peer healthcare and medical device funds.

Weekly Report: what happened at XHE last week (0311-0315)?

2024 Outlook: A New 'Super Boom'? Or Chop And Churn?

Weekly Report: what happened at XHE last week (0304-0308)?

Why Biotech Stocks May Be Ready For A Recovery

Biotech stocks have struggled in recent quarters as high interest rates take a toll on the capital-intensive sector. Jared Ablass, Vice President, Portfolio Research at TD Asset Management, speaks with MoneyTalk's Greg Bonnell about how the biotech sector could benefit once rates start to come down. Why beaten down Biotech stocks could be ready for a recovery.

XHE: Could Benefit From Rotation And Catch-Up Against Broader Healthcare

Weekly Report: what happened at XHE last week (0226-0301)?

Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?

Are Healthcare Stocks A Risky Prescription In A U.S. Election Year?

Weekly Report: what happened at XHE last week (0219-0223)?